Literature DB >> 28290462

Expert consensus document: Semantics in active surveillance for men with localized prostate cancer - results of a modified Delphi consensus procedure.

Sophie M Bruinsma1, Monique J Roobol1, Peter R Carroll2, Laurence Klotz3, Tom Pickles4, Caroline M Moore5, Vincent J Gnanapragasam6, Arnauld Villers7, Antti Rannikko8, Riccardo Valdagni9, Mark Frydenberg10, Yoshiyuki Kakehi11, Christopher P Filson12, Chris H Bangma1.   

Abstract

Active surveillance (AS) is broadly described as a management option for men with low-risk prostate cancer, but semantic heterogeneity exists in both the literature and in guidelines. To address this issue, a panel of leading prostate cancer specialists in the field of AS participated in a consensus-forming project using a modified Delphi method to reach international consensus on definitions of terms related to this management option. An iterative three-round sequence of online questionnaires designed to address 61 individual items was completed by each panel member. Consensus was considered to be reached if ≥70% of the experts agreed on a definition. To facilitate a common understanding among all experts involved and resolve potential ambiguities, a face-to-face consensus meeting was held between Delphi survey rounds two and three. Convenience sampling was used to construct the panel of experts. In total, 12 experts from Australia, France, Finland, Italy, the Netherlands, Japan, the UK, Canada and the USA participated. By the end of the Delphi process, formal consensus was achieved for 100% (n = 61) of the terms and a glossary was then developed. Agreement between international experts has been reached on relevant terms and subsequent definitions regarding AS for patients with localized prostate cancer. This standard terminology could support multidisciplinary communication, reduce the extent of variations in clinical practice and optimize clinical decision making.

Entities:  

Mesh:

Year:  2017        PMID: 28290462     DOI: 10.1038/nrurol.2017.26

Source DB:  PubMed          Journal:  Nat Rev Urol        ISSN: 1759-4812            Impact factor:   14.432


  17 in total

Review 1.  The Delphi technique: myths and realities.

Authors:  Catherine Powell
Journal:  J Adv Nurs       Date:  2003-02       Impact factor: 3.187

2.  Stability of response characteristics of a Delphi panel: application of bootstrap data expansion.

Authors:  Ralitsa B Akins; Homer Tolson; Bryan R Cole
Journal:  BMC Med Res Methodol       Date:  2005-12-01       Impact factor: 4.615

Review 3.  Active surveillance for prostate cancer: a systematic review of the literature.

Authors:  Marc A Dall'Era; Peter C Albertsen; Christopher Bangma; Peter R Carroll; H Ballentine Carter; Matthew R Cooperberg; Stephen J Freedland; Laurence H Klotz; Christopher Parker; Mark S Soloway
Journal:  Eur Urol       Date:  2012-06-07       Impact factor: 20.096

Review 4.  Does language ambiguity in clinical practice justify the introduction of standard terminology? An integrative review.

Authors:  Hillegonda A Stallinga; Huib ten Napel; Gerard J Jansen; Jan H B Geertzen; Pieter F de Vries Robbé; Petrie F Roodbol
Journal:  J Clin Nurs       Date:  2014-05-10       Impact factor: 3.036

Review 5.  An evidence review of active surveillance in men with localized prostate cancer.

Authors:  Stanley Ip; Issa J Dahabreh; Mei Chung; Winifred W Yu; Ethan M Balk; Ramon C Iovin; Paul Mathew; Tony Luongo; Tomas Dvorak; Joseph Lau
Journal:  Evid Rep Technol Assess (Full Rep)       Date:  2011-12

6.  Prognostic Gleason grade grouping: data based on the modified Gleason scoring system.

Authors:  Phillip M Pierorazio; Patrick C Walsh; Alan W Partin; Jonathan I Epstein
Journal:  BJU Int       Date:  2013-03-06       Impact factor: 5.588

7.  A Contemporary Prostate Cancer Grading System: A Validated Alternative to the Gleason Score.

Authors:  Jonathan I Epstein; Michael J Zelefsky; Daniel D Sjoberg; Joel B Nelson; Lars Egevad; Cristina Magi-Galluzzi; Andrew J Vickers; Anil V Parwani; Victor E Reuter; Samson W Fine; James A Eastham; Peter Wiklund; Misop Han; Chandana A Reddy; Jay P Ciezki; Tommy Nyberg; Eric A Klein
Journal:  Eur Urol       Date:  2015-07-10       Impact factor: 20.096

8.  Protocol of the COSMIN study: COnsensus-based Standards for the selection of health Measurement INstruments.

Authors:  L B Mokkink; C B Terwee; D L Knol; P W Stratford; J Alonso; D L Patrick; L M Bouter; H C W de Vet
Journal:  BMC Med Res Methodol       Date:  2006-01-24       Impact factor: 4.615

Review 9.  Functional MRI in prostate cancer detection.

Authors:  Sandeep Sankineni; Murat Osman; Peter L Choyke
Journal:  Biomed Res Int       Date:  2014-07-23       Impact factor: 3.411

10.  Reporting Magnetic Resonance Imaging in Men on Active Surveillance for Prostate Cancer: The PRECISE Recommendations-A Report of a European School of Oncology Task Force.

Authors:  Caroline M Moore; Francesco Giganti; Peter Albertsen; Clare Allen; Chris Bangma; Alberto Briganti; Peter Carroll; Masoom Haider; Veeru Kasivisvanathan; Alex Kirkham; Laurence Klotz; Adil Ouzzane; Anwar R Padhani; Valeria Panebianco; Peter Pinto; Philippe Puech; Antti Rannikko; Raphaele Renard-Penna; Karim Touijer; Baris Turkbey; Heinrik van Poppel; Riccardo Valdagni; Jochen Walz; Ivo Schoots
Journal:  Eur Urol       Date:  2016-06-24       Impact factor: 20.096

View more
  21 in total

1.  Radical prostatectomy versus deferred treatment for localised prostate cancer.

Authors:  Robin Wm Vernooij; Michelle Lancee; Anne Cleves; Philipp Dahm; Chris H Bangma; Katja Kh Aben
Journal:  Cochrane Database Syst Rev       Date:  2020-06-04

2.  Extended Focal Ablation of Localized Prostate Cancer With High-Frequency Irreversible Electroporation: A Nonrandomized Controlled Trial.

Authors:  Haifeng Wang; Wei Xue; Weigang Yan; Lei Yin; Baijun Dong; Biming He; Yongwei Yu; Wentao Shi; Zhien Zhou; Hengzhi Lin; Yi Zhou; Yanqing Wang; Zhenkai Shi; Shancheng Ren; Xu Gao; Linhui Wang; Chuanliang Xu
Journal:  JAMA Surg       Date:  2022-08-01       Impact factor: 16.681

3.  Feasibility of aspirin and/or vitamin D3 for men with prostate cancer on active surveillance with Prolaris® testing.

Authors:  Eoin Dinneen; Gregory L Shaw; Roseann Kealy; Panos Alexandris; Kier Finnegan; Kimberley Chu; Nadia Haidar; Sara Santos-Vidal; Sakunthala Kudahetti; Caroline M Moore; Alistair D R Grey; Daniel M Berney; Anju Sahdev; Paul J Cathcart; R Timothy D Oliver; Prabhakar Rajan; Jack Cuzick; Jack Cuzick; Sanjeev Madaan; Jhumur Pati; Abdul M Chowdhury; Brian R P Birch; Timothy J Dudderidge; Caroline M Moore; Alistair D R Grey; Gregory L Shaw; Kieran P Jefferson; Howard G Kynaston; Prabhakar Rajan; James S A Green; Paul J Cathcart; Daniel M Berney; Thomas Powles; R Timothy D Oliver; Anju Sahdev; Roseann Kealy; Victoria Kemp; Panos Alexandris; Kier Finnegan; Kimberly Chu
Journal:  BJUI Compass       Date:  2022-06-11

Review 4.  Considering the role of radical prostatectomy in 21st century prostate cancer care.

Authors:  Anthony J Costello
Journal:  Nat Rev Urol       Date:  2020-02-21       Impact factor: 14.432

Review 5.  Consensus on molecular imaging and theranostics in neuroendocrine neoplasms.

Authors:  Valentina Ambrosini; Jolanta Kunikowska; Eric Baudin; Lisa Bodei; Catherine Bouvier; Jaume Capdevila; Marta Cremonesi; Wouter W de Herder; Clarisse Dromain; Massimo Falconi; Melpomeni Fani; Stefano Fanti; Rodney J Hicks; Levent Kabasakal; Gregory Kaltsas; Val Lewington; Silvia Minozzi; Michela Cinquini; Kjell Öberg; Wim J G Oyen; Dermot O'Toole; Marianne Pavel; Philippe Ruszniewski; Aldo Scarpa; Jonathan Strosberg; Anders Sundin; David Taïeb; Irene Virgolini; Damian Wild; Ken Herrmann; James Yao
Journal:  Eur J Cancer       Date:  2021-02-12       Impact factor: 9.162

Review 6.  Patient and provider experiences with active surveillance: A scoping review.

Authors:  Claire Kim; Frances C Wright; Nicole J Look Hong; Gary Groot; Lucy Helyer; Pamela Meiers; May Lynn Quan; Robin Urquhart; Rebecca Warburton; Anna R Gagliardi
Journal:  PLoS One       Date:  2018-02-05       Impact factor: 3.240

Review 7.  Magnetic resonance imaging in active surveillance-a modern approach.

Authors:  Francesco Giganti; Caroline M Moore
Journal:  Transl Androl Urol       Date:  2018-02

Review 8.  Active surveillance for prostate cancer: a systematic review of contemporary worldwide practices.

Authors:  Netty Kinsella; Jozien Helleman; Sophie Bruinsma; Sigrid Carlsson; Declan Cahill; Christian Brown; Mieke Van Hemelrijck
Journal:  Transl Androl Urol       Date:  2018-02

9.  Low-risk prostate cancer selected for active surveillance with negative MRI at entry: can repeat biopsies at 1 year be avoided? A pilot study.

Authors:  Jonathan Olivier; Veeru Kasivisvanathan; Elodie Drumez; Jean-Christophe Fantoni; Xavier Leroy; Philippe Puech; Arnauld Villers
Journal:  World J Urol       Date:  2018-07-23       Impact factor: 4.226

10.  Understanding reasons for non-adherence to active surveillance for low-intermediate risk prostate cancer.

Authors:  Kerri Beckmann; Declan Cahill; Christian Brown; Mieke Van Hemelrijck; Netty Kinsella
Journal:  Transl Androl Urol       Date:  2021-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.